Author:
Yamaguchi H,Chen C-T,Chou C-K,Pal A,Bornmann W,Hortobagyi G N,Hung M-C
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Reference58 articles.
1. Baek SJ, Wilson LC, Hsi LC, Eling TE . (2003). Troglitazone, a peroxisome proliferator-activated receptor gamma (PPAR gamma ) ligand, selectively induces the early growth response-1 gene independently of PPAR gamma. A novel mechanism for its anti-tumorigenic activity. J Biol Chem 278: 5845–5853.
2. Bolden JE, Peart MJ, Johnstone RW . (2006). Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov 5: 769–784.
3. Bouillet P, Zhang LC, Huang DC, Webb GC, Bottema CD, Shore P et al. (2001). Gene structure alternative splicing, and chromosomal localization of pro-apoptotic Bcl-2 relative Bim. Mamm Genome 12: 163–168.
4. Brader KR, Wolf JK, Hung MC, Yu D, Crispens MA, van Golen KL et al. (1997). Adenovirus E1A expression enhances the sensitivity of an ovarian cancer cell line to multiple cytotoxic agents through an apoptotic mechanism. Clin Cancer Res 3: 2017–2024.
5. Burgess A, Ruefli A, Beamish H, Warrener R, Saunders N, Johnstone R et al. (2004). Histone deacetylase inhibitors specifically kill nonproliferating tumour cells. Oncogene 23: 6693–6701.
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献